E Fund Management (HK)’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-82,587
Closed -$2.75M 36
2023
Q1
$2.75M Buy
82,587
+23,014
+39% +$883K 1.53% 13
2022
Q4
$1.83M Sell
59,573
-17
-0% -$536 1.55% 13
2022
Q3
$2.04M Hold
59,590
1.62% 14
2022
Q2
$2.07M Buy
59,590
+14,377
+32% +$507K 1.43% 17
2022
Q1
$1.94M Buy
45,213
+26,250
+138% +$1.27M 1.23% 19
2021
Q4
$1.19M Buy
+18,963
New +$1.61M 0.66% 16
2021
Q2
$3.42M Buy
19,353
+487
+3% +$78.3K 2.13% 16
2021
Q1
$2.52M Buy
18,866
+656
+4% +$102K 0.81% 20
2020
Q4
$2.46M Buy
18,210
+3,811
+26% +$388K 0.85% 17
2020
Q3
$1.2M Buy
14,399
+3,918
+37% +$315K 0.46% 21
2020
Q2
$861K Buy
10,481
+2,330
+29% +$158K 0.42% 25
2020
Q1
$420K Buy
+8,151
New +$425K 0.24% 30

Other funds holding ZLAB

E Fund Management (HK)'s ZLAB Position: Q2 2023 in Review

E Fund Management (HK) sold out of Zai Lab (ZLAB) in Q2 2023, closing a stake of 82,587 shares — an estimated $2.75M sold.

E Fund Management (HK) first reported a position in ZLAB in Q1 2020 and held it in 12 quarters. The position peaked at $3.42M in Q2 2021. 137 funds tracked by Wall St. Rank hold ZLAB as of Q2 2023.

  • E Fund Management (HK) reported no remaining Zai Lab position as of Q2 2023 after selling out during the quarter.
  • E Fund Management (HK) sold 82,587 Zai Lab shares in Q2 2023, an estimated $2.75M.
  • E Fund Management (HK) first reported a position in Zai Lab in Q1 2020 and held it in 12 quarters.
  • E Fund Management (HK)'s Zai Lab position peaked at $3.42M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Zai Lab as of Q2 2023.

Based on E Fund Management (HK)'s 13F filing for Q2 2023, filed 18 Jul 2023.